Codexis, Inc. is an industrial biotechnology company that specializes in engineers enzymes for pharmaceutical and chemical production through biocatalysis. Codexis’ technologies enable scale-up and implementation of biocatalytic solutions to optimize process development, from research to manufacturing. There are currently over 50 pharmaceutical firms using Codexis’ technology, products and services in their manufacturing process development.
Codexis creates its products by applying its CodeEvolver® directed evolution technology platform, which introduces genetic mutations into microorganisms.
Codexis, Inc. began operations as an independent company in 2002, and became a publicly traded company in 2009. They are located in Redwood City, CA USA

Type
Public
HQ
Redwood City, US
Founded
2002
Size (employees)
91 (est)-37%
Codexis was founded in 2002 and is headquartered in Redwood City, US

Key People at Codexis

John Nicols

John Nicols

President & CEO
James Lalonde

James Lalonde

Senior Vice President, Research & Development

Codexis Office Locations

Codexis has an office in Redwood City
Redwood City, US (HQ)
200 Penobscot Dr

Codexis Data and Metrics

Codexis Financial Metrics

Codexis's revenue was reported to be $48.8 m in 2016
USD

Revenue (Y, 2016)

48.8 m

Revenue growth (Y, 2015 - Y, 2016), %

17%

Gross profit (Y, 2016)

39.1 m

Gross profit margin (Y, 2016), %

80%

Net income (Y, 2016)

(8.6 m)

EBIT (Y, 2016)

(8.6 m)

Market capitalization (26-Jun-2017)

250.5 m

Closing share price (26-Jun-2017)

5.2

Cash (31-Dec-2016)

19.2 m
Codexis's current market capitalization is $250.5 m.
USDFY, 2013FY, 2014FY, 2015Y, 2016

Revenue

31.9 m35.3 m41.8 m48.8 m

Revenue growth, %

11%18%17%

Cost of goods sold

9.8 m

Gross profit

39.1 m

Gross profit Margin, %

80%

Operating expense total

73.1 m54.4 m49.6 m57.4 m

EBIT

(41.1 m)(19.1 m)(7.8 m)(8.6 m)

EBIT margin, %

(129%)(54%)(19%)(18%)

Interest income

60 k18 k19 k60 k

Pre tax profit

(41.4 m)(19.3 m)(7.9 m)(8.6 m)

Income tax expense

(87 k)(256 k)

Net Income

(41.3 m)(19.1 m)(7.6 m)(8.6 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

22.1 m26.5 m23.3 m19.2 m

Inventories

1.5 m1.4 m992 k825 k

Current Assets

35.8 m33 m32.8 m27.2 m

PP&E

8.4 m4 m3.1 m2.2 m

Goodwill

3.2 m3.2 m3.2 m3.2 m

Total Assets

58.8 m48.1 m44.6 m35.6 m

Accounts Payable

4 m4.7 m3.4 m4.2 m

Current Liabilities

11.2 m13.7 m14.8 m12.4 m

Additional Paid-in Capital

298.4 m302.4 m306 m311.2 m

Retained Earnings

(256.9 m)(275.9 m)(283.5 m)(292.1 m)

Total Equity

22.9 m19.1 m

Financial Leverage

2 x1.9 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(41.3 m)(19.1 m)(7.6 m)(8.6 m)

Accounts Receivable

1.6 m1.6 m(3.5 m)1.4 m

Inventories

(185 k)92 k403 k167 k

Accounts Payable

308 k713 k(1.3 m)942 k

Cash From Operating Activities

(23 m)321 k(433 k)(2.7 m)

Purchases of PP&E

(1.2 m)(302 k)(1.2 m)(888 k)

Cash From Investing Activities

13.3 m4.6 m(1.3 m)(842 k)

Cash From Financing Activities

(147 k)(611 k)(1.5 m)(490 k)

Income Taxes Paid

103 k15 k8 k5 k
Y, 2016

Financial Leverage

1.9 x

Codexis Market Value History

Codexis Online and Social Media Presence

Codexis Company Life and Culture

You may also be interested in